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Abstract
Foot-and-mouth disease virus (FMDV) is one of the most contagious viruses of animals and is recognised as the most
important constraint to international trade in animals and animal products. Two fundamental problems remain to be
understood before more effective control measures can be put in place. These problems are the FMDV ‘‘carrier state’’ and
the short duration of immunity after vaccination which contrasts with prolonged immunity after natural infection. Here we
show by laser capture microdissection in combination with quantitative real-time reverse transcription polymerase chain
reaction, immunohistochemical analysis and corroborate by in situ hybridization that FMDV locates rapidly to, and is
maintained in, the light zone of germinal centres following primary infection of naı ¨ve cattle. We propose that maintenance
of non-replicating FMDV in these sites represents a source of persisting infectious virus and also contributes to the
generation of long-lasting antibody responses against neutralising epitopes of the virus.
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Introduction
Foot-and-mouth disease virus (FMDV) causes an acute vesicular
disease which is endemic throughout large parts of Asia, Africa and
South America [1]. Although the disease has been eradicated in
Europe and North America, introduction of infection, as occurred
in the United Kingdom in 2001, can cause devastating outbreaks of
disease [2]. Despite the availability of vaccines, control of such
outbreaks continues to rely on detection and slaughter of affected
herds [1]. One of the features of FMDV infection that has a major
impact on control policies is the ‘‘carrier state’’ [3]. A carrier of
FMDV is defined as an animal from which live-virus can be
recovered from scrapings of the oropharynx after 28 days following
infection [4]. Over 50% of ruminants exposed to viral challenge,
whether vaccinated or not, can become carriers [1]. Recovery of
infectious virus from oropharyngeal scrapings of foot-and-mouth
disease (FMD) recovered cattle is intermittent and the titre of virus
recovered from carrier animals is low, often falling below the level
thought to be necessary for successful transmission to susceptible
animals [5]. Intermittent virus recovery may be related to the
heterogeneous nature of oropharyngeal samples with saliva, mucus
and cells present in varying quantities [3]. Although such carrier
animals have never convincingly been directly demonstrated to
transmit infection, they are perceived as a potential source of new
infections and consequently there is a reluctance to use vaccination
asa primarymeansofcontrolling outbreaksindisease-freecountries
[3]. Despite the potential epidemiological and immunological
significance, very little is known about the mechanism by which
the ‘‘carrier state’’ is established or maintained. In one series of
experiments, carriers were treated with dexamethasone in order to
depress their immune systems, and kept in contact with susceptible
cattle,butthishadthe reverseeffectofcausing the virustodisappear
from oropharyngeal scrapings, only to reappear once the treatment
was stopped [6]. There was no transmission between carrier and
susceptible cattle. Despite the uncertainty concerning the capacity
of the carrier animals to transmit virus, there is a requirement to
identify and remove these animals before a country or region can
declare freedom from infection and resume international animal
trade. Hence the infection status of a country can have a profound
impact on its economy [2].
Virus is cleared rapidly from blood during the acute stage of
FMD, coinciding closely with the emergence of an antiviral
antibody response. Viral RNA is detected in the blood of infected
cattle, using real-time reverse transcription polymerase chain
reaction (rRT-PCR), but becomes undetectable from as early as 3
to 5 days after onset of clinical signs. This is in contrast to
pharyngeal tissue including the soft palate, nasopharynx, orophar-
ynx, palatine tonsil and mandibular lymph node which have been
shown to contain viral RNA for up to 72 days after infection [7].
The significance of continued detection of viral RNA has not been
clear since FMDV proteins have not been detected, in previous
studies in these tissues, following the resolution of vesicular lesions.
Importantly, prior to this publication, FMDV proteins have not
been detected previously in lymphoid tissue in vivo at any stage of
infection and viral proteins have not been detected in any tissue
following resolution of vesicular lesions.
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Laser capture microdissection
Germinal centre (GC) and non-GC regions of the dorsal surface
of the palatum molle (dorsal soft palates), pharyngeal tonsils [8],
palatine tonsils, lateral retropharyngeal lymph nodes and man-
dibular lymph nodes obtained from four cattle 38 days post
contact exposure to FMDV serotype O were selected for laser
capture microdissection (LCM, Table 1, Figure S1). FMDV
genome was detected consistently by quantitative rRT-PCR
within the GC samples obtained by LCM (Figure S2 to S6). No
FMDV genome was detected in the epithelium of the dorsal soft
palates and pharyngeal tonsils (Figure S2 to S3). No FMDV
genome was detected in the crypt epithelium, glandular epithelium
and interfollicular regions of the palatine tonsils or the interfol-
licular regions of the mandibular lymph nodes and lateral
retropharyngeal lymph nodes (Figure S4 to S6). No FMDV
genome could be detected in GC samples obtained by LCM from
non-infected control animals (data not shown). Significantly more
FMDV genome copies per 10
8 copies of 28 s rRNA were detected
in replicates of six GCs from mandibular lymph nodes, compared
to similar replicates harvested from other tissue (Figure 1)
(Mandibular lymph node compared to lateral retropharyngeal
lymph node [p=0.0014], mandibular lymph node compared to
palatine tonsil [p=0.0376], mandibular lymph node compared to
pharyngeal tonsil [p=0.0392] and mandibular lymph node
compared to dorsal soft palate [p=0.0148]; ANOVA, Tukey
simultaneous test).
In situ hybridization
An optimised detection protocol with tyramide signal amplifi-
cation was compared to conventional chromagenic detection
(Figure S7) [9]. Tyramide signal amplification combined with
endogenous peroxidase and alkaline phosphatase quenching
enhanced the specific hybridization signal and reduced back-
ground signal compared to conventional detection. The FMDV
3D antisense RNA probes, control 3D sense probes and control
SVD RNA probes [9] were validated on FMDV infected and
mock infected BHK-21 cells and on tissue samples collected from
non-infected and FMDV infected animals (Figure S8 and S9).
Despite the obvious signal obtained when detecting positive strand
viral RNA in infected cells, it was difficult to detect negative strand
viral RNA by in situ hybridization. In situ hybridization of dorsal
soft palates, mandibular lymph nodes, palatine tonsils, pharyngeal
tonsils and lateral retropharyngeal lymph nodes from ten animals
14 to 38 days post contact infection supported the LCM results.
FMDV 3D RNA was identified in GCs of mandibular lymph
node, palatine tonsil and lateral retropharyngeal lymph node
sections but not in other compartments of these tissues (Figure 2).
Immunofluorescence confocal microscopy
To determine whether viral RNA was associated with viral
structural proteins; frozen sections from the dorsal soft palates,
pharyngeal tonsils, palatine tonsils, lateral retropharyngeal lymph
nodes and mandibular lymph nodes collected 29 to 38 days post
contact infection were analysed using a new set of virus-specific
monoclonal antibodies (MAbs) shown to be specific for confor-
mational, non-neutralising epitopes of the FMDV capsid. These
new MAbs immunoprecipitated FMDV capsid proteins, consistent
with previously published antibodies (Figure S10), yet did not
detect FMDV proteins by western blot and were non-neutralising
(data not shown). Also, the MAbs readily detected virus in bovine
tongue during acute infection (Figure S11), virus infected cells
(Figure S12) and rare infected cells in lymphoid tissue during acute
infection (Figure S13). The ability of the MAbs specific for FMDV
capsid to detect immune complexed virus on the surface of cells in
culture was also confirmed (Figure S14).
The anti-FMDV capsid MAbs gave a diffuse punctate pattern of
positive labelling which was restricted to GCs within lymphoid
tissue and confined to the light zone within the GC from 29 days
post infection (Table 2, Figure 3, 4 and S15). By contrast, the
FMDV non-structural proteins 3A and 3C could not be detected in
any of the tissues from animals after 28 days post contact infection
(Table 2, Figure 3) [10,11]. Antibodies specific for 3A and 3C
readily detected infected cells in FMDV vesicles and lymph tissue
during the acute phase of infection and in infected BHK-21 cells,
co-localising with FMDV capsid (Figure S11 to S13). Also, using
immunofluorescence confocal microscopy there was a lack of
Figure 1. Analysis of tissue 38 days post contact infection by
LCM in combination with quantitative rRT-PCR. FMDV copies per
10
8 copies of 28 s rRNA of GC samples positive for FMDV by
quantitative rRT-PCR versus tissue type from cattle 38 days post
contact infection (n=4 animals. Adjusted means6standard error of the
mean; ANOVA, general linear model). Approximately 100 bovine
peripheral blood mononuclear cells contain 10
8 copies of 28 s rRNA.
There was a statistically significant association between the quantity of
FMDV genome present in GC samples and type of tissue (p=0.0039,
Fisher’s exact test).
doi:10.1371/journal.pone.0003434.g001
Table 1. Laser microdissected GC samples processed by
quantitative rRT-PCR to detect FMDV*.
Tissue
Number of
positive
replicates
Number of
negative
replicates
Threshold cycle
values of positive
replicates
DSP 9 3 38.74 to 46.24
Pharyngeal tonsils 6 6 36.76 to 40.22
Palatine tonsils 7 5 35.73 to 39.92
RPLN 12 0 34.68 to 37.01
MLN 12 0 35.64 to 40.03
*Measured at 38 days post contact infection (n=4 animals). Only GC samples
were found to contain FMDV genome after 50 cycles [33].
DSP=dorsal soft palate.
RPLN=lateral retropharyngeal lymph node.
MLN=mandibular lymph node.
doi:10.1371/journal.pone.0003434.t001
FMDV Persists in GCs
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[12], in the GCs (Figure S16). The diffuse punctate pattern of
labelled viral capsid was shown to be localised to the light zone
follicular dendritic cell (FDC) network by co-labelling with an
antibody specific for light zone FDCs (Figure 4) [13]. Detailed
analysisofin situhybridizationandimmunohistochemistryshowed a
consistent punctate pattern (Figure S15). The punctate labelling
pattern observed in Figure S15 panel D is consistent with the
distribution pattern of iccosomes on FDCs [14]. This pattern is in
contrast to the diffuse cytoplasmic labelling pattern of cells observed
during acute infection in vivo and in infected cells in vitro (Compare
Figures 3 and 4 with Figure S11 to S13).
Discussion
We have shown that FMDV genome, using LCM and
quantitative rRT-PCR, can be detected consistently in GCs within
the dorsal soft palate, pharyngeal tonsil, palatine tonsil, lateral
Figure 2. Tissue localisation of FMDV by in situ hybridization.
Consecutive mandibular lymph node frozen sections harvested from
cattle 38 days post contact infection. (A) 3D antisense RNA probe
detecting sense FMDV 3D RNA (see Figure S15 for high power images).
(B) Lack of staining following hybridization with 3D sense RNA control
probe. (C) Positive staining of IgG1 mRNA in GC B-cells after
hybridization with IgG1 antisense RNA positive control probe. (D) Lack
of staining following hybridization with SVD antisense control probe.
No counterstain. Scale bars, (A, B, C)=200 mm, (D)=500 mm.
doi:10.1371/journal.pone.0003434.g002
Table 2. Immunohistochemical analysis of tissue 29 to 38
days post contact infection for FMDV capsid and non-
structural proteins*.
Tissue
Number of animals
sampled
FMDV capsid+ve
GCs**
DSP 17 0
Pharyngeal tonsils 10 0
Palatine tonsils 10 6
RPLN 10 8
MLN 22 22
*Tissue was negative by immunohistochemical analysis for FMDV non-structural
proteins.
**Number of animals with GCs positive for FMDV capsid.
DSP=dorsal soft palate.
RPLN=lateral retropharyngeal lymph node.
MLN=mandibular lymph node.
doi:10.1371/journal.pone.0003434.t002
Figure 3. Tissue localisation of FMDV proteins 29–38 days post infection. Mandibular lymph node GC sections 38 days post contact
infection. (A) FMDV capsid labelled green with MAb IB11, dark zone FDCs labelled red with MAb D46 [13]. (B) dark zone FDCs labelled red with MAb
D46, no signal detected with isotype primary control MAb TRT1 labelled green [38]. (C) No signal detected with FMDV non-structural protein 3A
labelled green with MAb 2C2 [10]. FMDV non-structural proteins could not be detected by immunohistochemical analysis of tissue from 29 to 38 days
post contact infection. (D) No primary or secondary antibodies highlighting autofluorescence associated with bovine GCs. (E) High power image of
(A). Nuclei stained blue (DAPI), scale bars=100 mm.
doi:10.1371/journal.pone.0003434.g003
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days post contact infection. Also, FMDV genome in these tissues
was restricted to the GC. These findings were confirmed with in situ
hybridization studies, which revealed FMDV 3D RNA in GCs of
lymphoid tissues but not in other compartments of these tissues.
Using MAbs specific for conformational, non-neutralising epitopes
of the FMDV capsid, we identified viral structural proteins
restricted to the light zone FDC network of GCs within mandibular
lymph nodes, lateral retropharyngeal lymph nodes and palatine
tonsils up to 38 days post contact infection, but not in the dorsal soft
palates or pharyngeal tonsils. The inability to detect FMDV capsid
in the dorsal soft palates and pharyngeal tonsils by immunohisto-
chemistry is in contrast to the clear detection of FMDV genome by
LCM. This inconsistency may be a consequence of differences in
assay sensitivity or genomic RNA persisting longer than virus [15].
Thediffusepunctate patternoflabelled viralcapsid intissuefrom 29
to 38 days post infection, similar to the FMDV genome staining
pattern detected by in situ hybridization, was in contrast to the
diffuse cytoplasmic pattern observed in cells during acute infection
in vivo and in infected cells in vitro.
The mandibular lymph nodes had notably more GCs containing
FMDV capsid compared to the lateral retropharyngeal lymph
nodes and palatine tonsils. This is consistent with the detection of
significantly more FMDV genome copies/10
8 copies of 28 s rRNA
in replicatesof six GCs from mandibular lymph nodes, compared to
similar replicates harvested from other tissues. FMDV capsid was
detected in mandibular lymph node GCs of all animals examined
between 29 to 38 days post contact infection (n=22), including five
animals where FMDV could not be recovered by virus isolation or
detected by rRT-PCR analysis of oropharyngeal scrapings collected
at post-mortem 29 to 34 days post infection using probang sampling
cups [3]. These results indicate that virus is likely to persist in all
Figure 4. Localisation of FMDV capsid proteins within the light zone FDC network 29–38 days post infection. (A–C) Mandibular lymph
node frozen sections 38 days post infection. (A) FMDV capsid protein labelled green with MAb IB11. (B) Light zone FDC network labelled red with
MAb CNA.42 [13]. (C) Merge image showing the diffuse punctate pattern associated with FMDV capsid (green) linked to the light zone FDC network
(red). (D–F) Non-infected control tissue. (D) No signal detected using MAb IB11 on control tissue. (G–I) No signal was detected on infected mandibular
lymph node sections with isotype matched control MAbs TRT1 (G) [38], or AV48 (H). Nuclei stained blue (DAPI), scale bars=20 mm.
doi:10.1371/journal.pone.0003434.g004
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mandibular lymph node is not surprising because afferent
lymphatics of the mandibular lymph nodes in the bovine drain
the oral cavity and tongue, which are important sites of viral
replication during the acute phase of infection. However, these
results do not support findings from previous studies which reported
detection of viral RNA by in situ hybridization and whole tissue
quantitative rRT-PCR in the dorsal soft palate epithelium in carrier
animals [7]. We did not detect viral RNA in the epithelial
compartments of all the tissues examined either by LCM and
quantitative rRT-PCR or in situ hybridization, although we
routinely detected viral RNA and capsid in GCs of these tissues.
Although MAbs specific for FMDV non-structural proteins 3A
and 3C could detect infected cells in vitro and in vivo during the
acute phase of infection, no FMDV non-structural proteins were
detected in any of the tissues examined from 29 days post contact
infection. The absence of detectable FMDV non-structural
proteins indicates that the presence of viral RNA is not associated
with active viral replication [10,11]. The finding of close co-
localisation of viral RNA and capsid conformational epitopes, in
the absence of non-structural proteins, supports the hypothesis that
FMD viral particles or immune complexes are maintained in GC
light zones in a non-replicating state. Interestingly, FMDV capsid
was detected in the light zone of mandibular lymph node GCs as
early as 3 to 4 days post intradermolingual challenge (n=4).
FMDV is known to use members of the integrin family to
initiate infection [12]. Current evidence from in vitro and in vivo
studies indicates that avb6 integrin serves as the major cellular
receptor for FMDV. Since the distribution of avb6 expression in
cattle, namely in epithelial cells in the tongue, interdigital skin and
coronary band [12] correlates closely with the sites of FMDV
replication, it is thought to determine the tissue tropism of the
virus. We have shown by immunofluorescence confocal micros-
copy that avb6 is not expressed in GCs, indicating that the early
localisation of FMDV to GC light zones is independent of avb6
expression. Binding of virus to light zone GC cells during the early
stages of infection may play an important role in facilitating a
FMDV B-cell response [16,17].
The results of these studies have important implications for
understanding both the mechanism of viral persistence and the ability
of FMDV infection to stimulate long-lasting antibody responses.
FDCs are known to be non-endocytic cells capable of capturing and
retaining antigen in the form of immune complexes for long periods
of time [18,19]. Retention of immune complexed FMDV particles
within lymphoid tissue represents a possible source of the infectious
material detected by pharyngeal sampling of infected cattle either by
direct harvesting of mucosal associated lymphoid tissue GCs or
sampling of secondary cells, for example macrophages, dendritic cells
or B-cells, able to support a low level virus replication cycle in the
presence of high levels of neutralising antibodies [20,21]. These cell
typesmayalsoactasasourceofinfectiousmaterialcapableofseeding
other remote sites for ongoing low level viral replication in the
pharynx. Of the tissue examined in the present study, only material
from the palatine tonsils and pharyngeal tonsils are likely to be
represented in probang samples. Viral RNA was detected in GCs of
palatine tonsils and pharyngeal tonsils but capsid antigen was only
detected in GCs of palatine tonsils making this tissue a likely source of
infectious virus detected by probang sampling in cattle. FDCs are
notoriously difficult cells to work with, so far we have been unable to
rescueinfectiousorimmunecomplexedFMDVfromlymphoidtissue
most likely due to technical difficulties working with the bovine
system. Retention of other viruses such as HIV in a replication-
competent state within the light zone of GCs has been reported and
the next step will require the development and interrogation of
murine model systems [22]. The previous observation that
dexamethasone treatment suppresses the ability to detect FMDV in
oropharyngeal scrapings [6] is consistent with the hypothesis that the
GC is the reservoir for infectious virus, since glucocorticoid
administration to mice is known to result in atrophy of the FDC
network [23]. The recrudescence of virus in pharyngeal scrapings
after dexamethasone treatment could be a consequence of the failure
of the treatment to completely eliminate structures capable of
maintaining viable virus. FDC-trapped HIV has been shown to
represent a significant reservoir of infectious and highly diverse HIV,
demonstrating greater genetic diversity than most other tissues,
providing drug-resistant and immune-escape quasispecies that
contribute to virus transmission, persistence and diversification
[24]. Retention of intact FMDV particles on the FDC network
would therefore provide an ideal mechanism of maintaining a highly
cytopathic and lytic virus like FMDV extracellularly in a non-
replicating, native, stable nondegraded state [22,25]. This reservoir
could serve as a source of genetically diverse viral mutants
(quasispecies) able to infect susceptible cells that come into contact
with the FDC network [26,27].
FMDV infection in ruminants elicits an immune response that
can provide protection for several years [28] and the level of
protection correlates well with specific serum neutralising antibody
titres (SNTs) [1]. This is in contrast to vaccination, with current
FMDV vaccines prepared with inactivated virus and adjuvants,
providing short term duration of SNTs and protection [29]. Long-
term maintenance of elevated, specific antibody levels in mice
following acute vesicular stomatitis virus (VSV) infection has been
shown to be associated with the co-localisation of antigen with
specific memory B-cells within long-lived GCs [30]. VSV is a
cytolytic virus that does not persist in an infectious form in mice,
thus highlighting the function of FDC trapping and retention
serving as a long-term repository of immunogenic antigen for
maintenance of SNTs. Hence, efficient retention within the GCs of
intact viral capsids, as opposed to the constituent viral proteins, may
be a requirement for sustaining antibody responses relevant for
providing protection against challenge. Indeed, in a recent review of
the functional significance of antigen retained on FDC, Kosco-
Vilbois suggests the observation that B-cell responses are indepen-
dent of FDC-associated antigen is only valid in mice that are
immunised with forms of antigen that leave persistent depots [31].
Therefore, we believe that long-term antibody responses detectable
after FMDV infection are maintained in part by antigen persisting
on FDCs. Based on the evidence presented here we suggest the
persistence of FMDV after acute infection is both a consequence of
the host immune response and a requirement for the long-term
maintenance of protective virus-specific antibody responses.
Materials and Methods
Challenge
The cattle examined in this study were infected by close contact
with cattle infected with FMDV isolates O/UKG/34/2001 or
O1BFS1860. Animal experimentation was approved by the
Institute for Animal Health (IAH) ethical review board under
the authority of a Home Office project licence in accordance to
the Home Office Guidance on the Operation of the Animals
(Scientific Procedures) Act 1986 and associated guidelines.
Laser capture microdissection
LCM was performed as described previously [32], except that
ethanol fixed frozen sections were stained with a 1% solution of
toluidine blue (Fluka) for 3 minutes, washed for 30 seconds in
nuclease free water, dehydrated by a graded ethanol series and
FMDV Persists in GCs
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tissues regions, each containing six microdissected samples
collected in the caps of RNase-free PCR tubes (Ambion), were
collected from each tissue for RNA isolation with the RNeasy
Micro Kit (Qiagen) and processed by quantitative rRT-PCR.
Quantitative rRT-PCR
Reverse transcription of isolated RNA was performed concur-
rently with 10-fold dilution series of FMDV and bovine 28 s
standard RNA (Applied Biosystems). Standard RNA of FMDV O/
UKG/34/2001 internal ribosomal entry site was prepared as
previously described [33]. Bovine 28 s standard RNA was
synthesised from a plasmid containing a 261 base pair PCR
product insert of bovine peripheral blood mononuclear cell 28 s
ribosomal RNA. Linearised plasmid was transcribed with a
MegascriptH T7 kit (Ambion) and subjected to TURBO DNase
TM
treatment and removal reagents (Ambion). The molecular weight of
the entire 295 nt product was calculated and number of copies/ml
determined as previously described [34]. FMDV primer/probe sets
and detection were as previously described; samples with no
detectable fluorescence above threshold after 50 cycles were taken
to be negative [33]. 28 s primer/probe sets and detection were
adapted from methods previously described [35]. There was no
statistically significant association between FMDV genome copies
expressedas FMDV copies/10
8 copiesof28 s rRNAand amount of
28 s rRNA per reaction (p=0.206. ANOVA, general linear model).
Selection of MAbs specific for conformational, non-
neutralising epitopes of the FMDV capsid
Mouse MAbs IB11, FC6, AD10 and BF8 raised against 146 S
FMDV type O1 antigen were selected by ELISA and virus
neutralising antibody test as described in the Office International
des Epizooties (OIE) Manual of Diagnostic Tests and Vaccines for
Terrestrial Animals, 5
th edition, 2004. Immunoprecipitation
analysis was performed as previously described by Rouiller et al
[36], BHK-21 cells were infected with O1BFS at MOI 5 for four
hours in total and pulsed with 35S methionine/cysteine for two of
these hours. Cells were lysed and immunoprecipitated with D9
(kindly provided by E Brocchi, Istituto Zooprofilattico Sperimen-
tale della Lombardia e dell’Emilia Romagna Reparto Biotecno-
logie, Italy) [37], IB11, FC6, AD10, BF8 and TRT1 [38] coupled
to protein G sepharose. MAbs were subsequently screened by
western blotting analysis and on FMDV vesicular lesions, non-
infected tissue and on infected and mock-infected cells by
immunofluorescence microscopy in combination with MAb 2C2
(anti-FMDV 3D) [10] and MAb 3C1 (anti-FMDV 3C) [11] kindly
provided by E Brocchi.
Immunofluorescence confocal microscopy
Samples collected at post-mortem were snap frozen in O.C.T.
compound (Tissue-Tek) and stored at 280uC until processing.
Acetone fixed frozen sections of acute tissue and tissue from 29 to
38 days post contact infection were labelled in duplicate with
FMDV capsid MAbs, with consecutive sections labelled with
MAbs 2C2, 3C1 [10,11] and isotype control MAbs TRT1, TRT3
[38] and AV29, a MAb directed against a chicken antigen
provided by F Davison, IAH. Additional sections were labelled
with MAb D46 (specific for dark zone FDCs) [13], MAb CNA.42
(specific for light zone FDCs, kindly provided by G Delsol,
Toulouse, CHU Purpan, Laboratoire d’anatomie et cytologie
pathologiques, France) [13], MAb CC51 (anti-bovine CD21) [39],
MAb 10D5 (anti-avb6, Chemicon) [12] and control MAb AV48, a
MAb directed against a chicken antigen provided by F Davison,
IAH. Anti-bovine CD32 MAbs CCG36 and CCG37 were kindly
provided by C Howard, IAH. Goat anti-mouse Molecular Probes
Alexa-Fluor-conjugated secondary MAbs (Invitrogen) were used
and nuclei were stained with DAPI (Sigma). All data were
collected sequentially using a Leica SP2 scanning laser confocal
microscope.
In situ hybridization
An optimised In situ hybridization method for the detection of
FMDV was developed using digoxigenin-labelled RNA probes
based on the protocol described by Prato Murphy et al [9] and
optimised for frozen sections incorporating pre-hybridization
blocking steps, tyramide signal amplification and alkaline phos-
phatase based visualization as described by Yang et al [40].
Consecutive frozen sections were simultaneously probed with;
500 nt 3D antisense and sense RNA probes specific for serotype
O/UKG/34/2001 non-structural protein 3D coding sequence,
IgG1 antisense RNA probe (686 nt) for the CH2, CH3 and hinge
region of bovine IgG1 mRNA and a 615 nt swine vesicular disease
virus probe specific for structural proteins 1C and 1D coding
sequence [9].
Supporting Information
Figure S1 Analysis of tissue 38 days post contact infection by
LCM in combination with quantitative rRT-PCR. (A–C) Frozen
sections stained with toluidine blue highlighting regions targeted
during LCM. (A) Mandibular lymph node (MLN) and lateral
retropharyngeal lymph node (RPLN) germinal centre and
interfollicular regions targeted for microdissection. (B) Palatine
tonsil (palatine t) germinal centre, interfollicular region, glandular
epithelium and crypt epithelium targeted for microdissection. (C)
Dorsal soft palate (DSP) and pharyngeal tonsil (pharyngeal t)
germinal centres and epithelium targeted for microdissection.
Three replicates of the different tissues regions, each containing six
microdissected samples, were collected from each tissue and
processed by quantitative rRT-PCR. Scale bars=200 mm.
Found at: doi:10.1371/journal.pone.0003434.s001 (6.74 MB TIF)
Figure S2 Dorsal soft palate samples analysed at 38 days post
contact infection by LCM in combination with quantitative rRT-
PCR to detect FMDV genome. FMDV genome was restricted to
germinal centre samples (n=4 animals, each bar represents six
microdissected samples). No fluorescent signal above threshold was
detected in epithelial samples by rRT-PCR after 50 cycles [33].
Found at: doi:10.1371/journal.pone.0003434.s002 (0.68 MB TIF)
Figure S3 Pharyngeal tonsil samples analysed at 38 days post
contact infection by LCM in combination with quantitative rRT-
PCR to detect FMDV genome. FMDV genome was restricted to
germinal centre samples (n=4 animals, each bar represents six
microdissected samples). No fluorescent signal above threshold was
detected in epithelial samples by rRT-PCR after 50 cycles [33].
Found at: doi:10.1371/journal.pone.0003434.s003 (0.67 MB TIF)
Figure S4 Palatine tonsil samples analysed at 38 days post
contact infection by LCM in combination with quantitative rRT-
PCR to detect FMDV genome. FMDV genome was restricted to
germinal centre samples (n=4 animals, each bar represents six
microdissected samples). No fluorescent signal above threshold was
detected in interfollicular, crypt epithelium or glandular epitheli-
um samples by rRT-PCR after 50 cycles [33].
Found at: doi:10.1371/journal.pone.0003434.s004 (1.14 MB TIF)
Figure S5 Lateral retropharyngeal lymph node samples ana-
lysed at 38 days post contact infection by LCM in combination
FMDV Persists in GCs
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genome was restricted to germinal centre samples (n=4 animals,
each bar represents six microdissected samples). No fluorescent
signal above threshold was detected in interfollicular samples by
rRT-PCR after 50 cycles [33].
Found at: doi:10.1371/journal.pone.0003434.s005 (0.70 MB TIF)
Figure S6 Mandibular lymph node samples analysed at 38 days
post contact infection by LCM in combination with quantitative
rRT-PCR to detect FMDV genome. FMDV genome was
restricted to germinal centre samples (n=4 animals, each bar
represents six microdissected samples). No fluorescent signal above
threshold was detected in interfollicular samples by rRT-PCR
after 50 cycles [33].
Found at: doi:10.1371/journal.pone.0003434.s006 (0.70 MB TIF)
Figure S7 In situ hybridization detection protocol: comparison of
tyramide signal amplification with conventional chromagenic
detection. Detection protocols were compared and optimised on
consecutive pharyngeal tonsil frozen sections using IgG1 RNA
probes. (A) IgG1 antisense probe detected with tyramide signal
amplification protocol showing deposits of blue-back chromagen
in target cells with low background after developing for 2 minutes.
(B) IgG1 antisense probe detected with conventional chromagen
protocol [9] after developing for 2 minutes. No blue-black deposit
could be seen. (C) IgG1 antisense probe detected with conven-
tional chromagen protocol [9] after developing for 30 minutes.
Deposits of blue-back chromagen can be seen in target cells but
high background signal make the detection of rare mRNA
difficult. (D) Background signal associated with IgG1 antisense
probe and tyramide signal amplification after developing for
30 minutes. Scale bars, (A, C, D)=500 mm, (B)=200 mm.
Found at: doi:10.1371/journal.pone.0003434.s007 (10.44 MB
TIF)
Figure S8 3D antisense RNA probe validation on infected and
mock-infected BHK-21 cells. (A) Positive signal following hybrid-
ization with 3D antisense RNA probe on BHK-21 cells fixed
5 hours after FMDV O/UKG/34/2001 infection at MOI 10. (B)
Lack of specific signal on infected cells with SVD antisense probe.
(C) Lack of specific signal on mock-infected cells following
hybridization with 3D antisense probe. (D) Positive, cytoplasmic
blue-black chromagen deposit on infected cells following hybrid-
ization with 3D antisense probe. (E) Faint blue-black chromagen
deposit following hybridization with 3D sense probe 5 hours after
FMDV infection at MOI 10. Scale bars, (A, B)=500 mm, (C, D,
E)=25 mm.
Found at: doi:10.1371/journal.pone.0003434.s008 (3.49 MB TIF)
Figure S9 In situ hybridization validation: 3D antisense RNA
probe used on frozen sections 4 days post infection. Tissue samples
were collected from animals 4 days post contact challenge. (A–B)
Positive staining of coronary band epithelium following hybrid-
ization with 3D antisense RNA probe. (C–D) Lack of staining of
coronary band epithelium following hybridization with SVD
antisense and 3D sense RNA probes. No signal was detected in
sections from non-infected control animals (data not shown). Scale
bars, (A)=200 mm, (B)=50 mm, (C, D)=500 mm.
Found at: doi:10.1371/journal.pone.0003434.s009 (4.49 MB TIF)
Figure S10 Detection of FMDV capsid proteins in cell culture.
SDS-PAGE analysis of virus infected (+) or mock-infected (2)
BHK-21 cell lysates immunoprecipitated with MAb D9 (+ve
control) [37], MAb IB11, BF8, AD10, FC6 and TRT1 (2ve
control) [38]. MAbs IB11, BF8, AD10 and FC6 did not detect
linearised FMDV by western blotting analysis (data not shown).
Found at: doi:10.1371/journal.pone.0003434.s010 (0.47 MB TIF)
Figure S11 Tongue epithelium frozen sections from infected
and non-infected animals labelled for immunofluorescence
confocal microscopy. (A–F) Infected tongue epithelium frozen
sections 4 days post contact challenge. (A) FMDV capsid proteins
labelled green with MAb IB11. (B) FMDV non-structural protein
3A labelled red with MAb 2C2 [10]. (C) Co-localisation of FMDV
capsid and 3A proteins. (D–F) No signal was detected on infected
tongue epithelium with isotype control MAbs TRT1 (D), or TRT3
(E) [38]. (G–I) No signal was detected with MAbs IB11 (G), or 2C2
(H) on non-infected control tissue. Nuclei stained blue (DAPI),
scale bars=80 mm (MAbs FC6, AD10, BF8 and FMDV anti-3C
MAb 3C1 showed a similar labelling pattern, data not shown)
[11].
Found at: doi:10.1371/journal.pone.0003434.s011 (10.11 MB
TIF)
Figure S12 Infected and mock-infected BHK-21 cells labelled
for immunofluorescence confocal microscopy. (A) FMDV capsid
proteins labelled green with MAb IB11 on cells fixed 5 hours after
FMDV O/UKG/34/2001 infection at MOI 10. (B) FMDV non-
structural protein 3A labelled red with MAb 2C2 [10]. (C) Co-
localisation of FMDV capsid and 3A proteins. (D) No signal was
detected with MAbs IB11 or 2C2 on mock-infected cells. (E) No
signal was detected on infected cells with isotype control MAbs
TRT1 or TRT3 [38]. Nuclei stained blue (DAPI), scale bars, (A,
B, C)=5 mm, (D, E)=10 mm (MAbs FC6, AD10, BF8 and
FMDV anti-3C MAb 3C1 showed a similar labelling pattern, data
not shown) [11].
Found at: doi:10.1371/journal.pone.0003434.s012 (7.46 MB TIF)
Figure S13 Mandibular lymph node frozen sections labelled to
detect FMDV proteins four days post contact challenge with O/
UKG/34/2001. (A–C) A small number of cells were detected with
MAbs to FMDV structural and non-structural proteins in the
lymph node cortex during the acute stages of FMDV infection. (A)
FMDV non-structural protein 3A labelled red with MAb 2C2
[10]. (B) FMDV capsid proteins labelled green with MAb IB11.
(C) Co-localisation of FMDV capsid and 3A proteins. (D–F)
Higher power image of lymph node cortex showing cytoplasmic
FMDV capsid and 3A protein co-localisation during the acute
stages of infection. No signal was detected with isotype control
MAbs TRT1 or TRT3 [38] or with MAbs IB11 and 2C2 on non-
infected control tissue (data not shown). Nuclei stained blue
(DAPI), scale bars, (A, B, C)=100 mm, (D, E, F)=20 mm.
Found at: doi:10.1371/journal.pone.0003434.s013 (2.22 MB TIF)
Figure S14 Detection of FMDV immune complexes in vitro.
(A–C) Mouse fibroblast cells (3T3 cells) expressing bovine CD32
were paraformaldehyde fixed, washed and incubated with FMDV
immune complexes prepared by incubating FMDV with heat
inactivated bovine polyclonal immune serum. Cells were subse-
quently washed, fixed and labelled. (A) FMDV capsid protein
labelled green with MAb IB11. (B) CD32 labelled red with MAb
CCG37. (D–F) Cells prepared as above except FMDV was
incubated with non-immune control serum. (D) No FMDV capsid
proteins were detected. (G–I) Cells prepared as above with FMDV
immune complexes and labelled. (G) No FMDV non-structural
protein 3A was detected with MAb 2C2 [10], consistent with lack
of replication and internalisation by fixed cells. (H) CD32 labelled
red with MAb CCG36. Nuclei stained blue (DAPI), scale
bars=10 mm.
Found at: doi:10.1371/journal.pone.0003434.s014 (10.08 MB
TIF)
Figure S15 High power images of FMDV detected in
mandibular lymph nodes 38 days post contact infection by in situ
FMDV Persists in GCs
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ular lymph node frozen sections analysed by in situ hybridization
with (A) 3D antisense RNA probe, (B) SVD antisense RNA control
probe and (C) 3D sense RNA control probe. No counterstain,
scale bar=50 mm. (D–F) Mandibular lymph node frozen sections
labelled for immunofluorescence confocal microscopy. (D) MAb
IB11 labelling FMDV capsid (green). (E) Isotype matched negative
control MAb TRT1 [38]. (F) Lack of signal on non-infected
control tissue labelled with IB11. Nuclei stained blue (DAPI), scale
bars=5 mm. Panel (A) and (D) highlight the similar diffuse
punctate pattern using in situ hybridization to detect FMDV
genome and MAb IB11 to detect FMDV capsid proteins.
Found at: doi:10.1371/journal.pone.0003434.s015 (10.45 MB
TIF)
Figure S16 The avb6 integrin is not expressed in germinal
centres. (A–F) Palatine tonsil frozen sections. (A) Palatine tonsil
crypt epithelium cells express the avb6 integrin labelled green with
MAB 10D5 [12], green fluorescence in the adjacent germinal
centre is due to autofluorescence associated with bovine germinal
centres. No avb6 expression was seen in germinal centres. (B)
CD21 expressing cells labelled with MAb CC51 [39]. (D–E)
Consecutive frozen sections labelled with isotype control MAb
TRT3 (D) [38] and AV29 (E). Nuclei stained blue (DAPI), scale
bar=100 mm.
Found at: doi:10.1371/journal.pone.0003434.s016 (9.67 MB TIF)
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